CAPITOL STRATEGIES, LLC

Lobbying for BIOLAB HOLDINGS, INC. · Biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Arizona · House · Senate · $20,000.00 income · posted Jul 14, 2026

Bills named in this filing 1

Lobbying activity 3

Health Issues

H.R. 5768 - Skin Substitute Access and Payment Reform Act and other skin substitute legislation

Medicare/Medicaid

Skin substitute issues

Budget/Appropriations

FY27 Labor, HHS, Education Appropriations - skin substitute language

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.